# A Study of NT 201 Doses in the Treatment of Platysma Prominence

> **NCT05773053** · PHASE2 · COMPLETED · sponsor: **Merz Aesthetics GmbH** · enrollment: 73 (actual)

## Conditions studied

- Platysma Prominence

## Interventions

- **DRUG:** NT 201
- **DRUG:** NT 201 Placebo

## Key facts

- **NCT ID:** NCT05773053
- **Lead sponsor:** Merz Aesthetics GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-22
- **Primary completion:** 2023-10-19
- **Final completion:** 2024-01-24
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2024-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05773053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05773053, "A Study of NT 201 Doses in the Treatment of Platysma Prominence". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05773053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*